M
ost patients who require mechanical ventilation during critical illness can be successfully liberated from respiratory support on recovery from the precipitating illness. For 2-5% of patients, however, the weaning process fails, conventionally defined as dependency on mechanical ventilation more than 3 weeks after resolution of the precipitating cause for admission to the intensive care unit (ICU). Specialist weaning centres, geographically distant from general ICUs, have been developed, mostly in the USA, to manage such weaning failure patients. Variable mortality and weaning success has been reported. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The Lane Fox Unit (LFU) is a 16-bed facility, staffed with a nurse to patient ratio of 3.5:1 and equipped to provide invasive (tracheostomy) and non-invasive (NIV) support. Before 1995, experience was largely in caring for chronic ventilator dependent patients in the community. A service was developed recognising the needs of a larger group of patients in general ICUs with weaning delay. A policy of transfer of responsibility of care and long term placement of those failing to wean was adopted. Exceptionally, patients considered unable to be weaned were transferred back to the referring institution after initial evaluation.
The unit provides all forms of ventilatory support including negative pressure tanks, cuirass jackets, rocking beds, and nose/face mask positive pressure techniques. Extensive use of NIV as a bridge, particularly in sleep, to spontaneous breathing underlies the approach to weaning. This is coupled with techniques to clear respiratory secretions (breath stacking, frog breathing, and insufflation/exsufflation). The weaning process involves daily targets of either increasing periods of T-piece ventilation and/or a gradual reduction in pressure support. Assist control ventilation was provided during sleep. Other aspects include identification of reversible causes of weaning failure (such as unnecessary steroids), avoidance of sedatives, restoration of normal sleep/ wake cycles, attention to nutrition, proactive physiotherapy including ambulatory ventilation, and attempts to improve patient autonomy such as establishing speech. This is a report of our experience over a 4 year period. We have examined the influence of the underlying diagnosis on the success of weaning and outcome, and also report on costs and long term survival which have only rarely been reported previously.
METHODS
The study was approved by the ethics committee of Guy's and St Thomas' Hospital. All patients transferred to the LFU between January 1997 and December 2000 were identified and included if referred because of evident or expected failure to wean from mechanical ventilation. The clinical notes, nursing charts, and computer databases were inspected and, when not otherwise available, additional information was sought from the referring hospital by letter and telephone. Patients transferred to other hospitals from the LFU were traced. Long term survival data were obtained by contacting the patients' general practitioners, referring hospitals, and by using death certificate data generated by the Office of National Statistics for England and Wales.
Reimbursement from the referring hospital or health authority was calculated from the Therapeutic Intervention Scoring System (TISS) using a method previously described for intensive care patients. 13 A fixed cost was calculated for each patient which reflected medical, technician and clerical salary costs as well as capital equipment depreciation, equipment and capital hospital costs. A variable cost was measured for each patient on a daily basis. This included nursing, physiotherapy, radiology, and pathology staff costs and consumables. Patients were scored until weaned from invasive ventilation or discharge from LFU, whichever came first.
Age, sex, principal underlying diagnosis, time ventilated in the referring ICU, duration of stay in LFU, APACHE II score on admission to the referring ICU, and cost of stay in LFU were recorded. Causes of respiratory failure leading to prolonged mechanical ventilation were classified into four diagnostic groups: neuromuscular/chest wall disorders; chronic obstructive pulmonary disease (COPD); surgical; and other diagnoses (which included conditions such as non-COPD respiratory disease, obesity hypoventilation, left ventricular failure, and central nervous system disorders).
Primary outcome measures were ventilator independence, hospital mortality, and long term mortality. Weaning success was defined as being free from any form of ventilatory assistance at discharge from hospital. Any requirement for ventilation during the day was classified as ''full ventilation'' as opposed to those who only required nocturnal ventilation. Patients who weaned from ventilation but died before leaving hospital were included in the deaths group rather than in the ''weaned from ventilation'' group.
Statistical analysis
All data were analysed using SAS Version 8.0 (SAS Institute Inc, Cary, NC, USA). Non-parametric data were expressed as median and interquartile range and a p value of ,0.05 was considered to be statistically significant. Univariate analysis was performed using t tests, logistic regression, x 2 tests for equal proportion, Spearman correlation coefficients, Wilcoxon rank sum tests, and log rank tests, where appropriate. Multivariate analysis was performed on survival time using Cox proportional hazards regression models. Kaplan-Meier survival curves are shown for the whole group and for the three largest diagnostic groups.
RESULTS
Between the beginning of January 1997 and end of December 2000, 153 patients (who had 157 admissions) were identified as weaning referrals to the LFU. One patient had three separate admissions and two further patients had two admissions each. These were all separate hospitalisation episodes. Over the study period nine patients were referred but not transferred. Four had associated neurological pathology that made weaning very unlikely, three weaned successfully while on the waiting list, and two died.
Demographic data of the group are shown in table 1. The three largest diagnostic groups were neuromuscular/chest wall disorders (31%, n = 47), COPD (27%, n = 41), and surgical (24%, n = 36). The surgical group consisted of 13 patients who had undergone cardiac surgery, seven gastrointestinal surgery, three major vascular surgery, three trauma, and 10 others. The neuromuscular/chest wall group comprised patients with chest wall disorders, neuropathies and myopathies (nine idiopathic kyphoscoliosis, eight postpolio syndrome, eight motor neurone disease, six GuillainBarré, four Duchenne's muscular dystrophy, four myotonic dystrophy, and eight others). Only two had neuropathy/ myopathy acquired in the ICU. Figure 1 shows the overall outcomes for the whole group. 53% of the 111 survivors were fully weaned from ventilation. Of the 27% (n = 42) who died before leaving hospital, two patients subsequently deteriorated and died despite initially weaning from ventilation. Re-institution of invasive support was considered inappropriate in both cases. There were 56 patients referred who had spent less than 21 days ventilated on the referring ICU. Mortality was lower in these patients (14% (8/56) v 34% (35/97); p = 0.01). However, there was no difference in eventual rates of ventilator independence (45% (25/56) v 34% (33/97); p = 0.26).
Of the survivors, 71% (79/111) were discharged directly home from the LFU and 9% (10/111) were transferred to other medical wards in the hospital before discharge home. Twenty eight patients were transferred to outside hospitals, six of whom died.
Fourteen patients (9%) had been receiving ventilatory support before admission to the ICU (six tracheostomy, eight NIV). Two of these patients had central hypoventilation due to cerebrovascular accidents, one had obesity hypoventilation, and the remainder had neuromuscular/chest wall conditions. One patient died and the 13 survivors continued to require ventilatory support at discharge.
The majority of patients (78%, n = 120) were ventilated via a tracheostomy on admission, but only 16% of survivors (n = 18) had a tracheostomy at discharge. Mini-tracheostomies to aid suctioning of secretions were used in a small number of patients who weaned from ventilation. In five out of six patients this was later removed. Table 2 shows the outcomes related to the diagnostic groups. Patients with neuromuscular and chest wall disorders had the lowest hospital mortality (15%) but also the lowest rate of weaning from ventilation (19%). The mortality of the COPD group (24%) was intermediate between the other two large diagnostic groups and was similar to the group as a whole (27%). Over half the patients with COPD (56%) were weaned from mechanical ventilation. Although surgical patients had the highest short term mortality (50%), most of the survivors were weaned from ventilation (72%, 13/ 18 survivors).
Factors associated with mortality and independence from mechanical ventilation Univariate analysis is shown in table 3. Age, duration of stay in the referring ICU, APACHE II risk of death, and a surgical cause for admission were associated with increasing mortality. Neuromuscular/chest wall conditions were associated with low mortality but also with a low likelihood of ventilator independence. Interestingly, a diagnosis of COPD was associated with an increased likelihood of weaning from mechanical ventilation. Female sex was associated with weaning from mechanical ventilation. There was a trend towards increasing ICU length of stay being related to a reduced rate of ventilator independence (p = 0.07). Referral from the ''in house'' ICU at St Thomas' Hospital was associated with an increased likelihood of weaning from ventilation. However, this group included 14 patients originally from external hospitals. 39% of patients (n = 59) were directly referred to the LFU from outside ICUs. Duration of stay in the referring ICU was higher among patients referred from external sources (median 41 days (IQR 25-67) v 21 days (IQR 9-35); p,0.001). There were more patients with neuromuscular/chest wall conditions referred from outside hospitals (27/59 v 20/94, p = 0.003). There were no other significant differences between patients from different referral sources. 
Cost analysis
There was a progressive (but not statistically significant) increase in the daily charge each year (o = 0.08, p = 0.4; table 4).
Long term survival
Data on 140 patients were available to assess long term survival ( fig 2) ; 58% were alive at 1 year and 47% at 3 years. Of the 13 patients who were lost to follow up, four had moved abroad and nine were no longer traceable after discharge. Figure 3 shows the long term survival for patients in the three main diagnostic groups who left hospital alive. The surgical and neuromuscular/chest wall patients had similar long term survival rates. Poorest survival was seen in the COPD group. After adjustment for age and time spent ventilated in the referring ICU, the differences in survival between these three groups were no longer significant.
DISCUSSION
Our study is the first from the UK to examine the outcome in weaning patients from prolonged mechanical ventilation with attention to economic factors, diagnostic issues, and long term survival.
We found an overall mortality rate of 27% and full ventilator independence of 38%. Other centres have reported mortality of 7-67% with rates of ventilator independence of 25-75%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] This reflects not only operational differences between units but also differences in selection criteria, variation in expertise, and differences in patient characteristics. Units with restrictive acceptance criteria have reported higher rates of success in achieving ventilator independence and better survival. 1 2 6 Referrals to the LFU were at the discretion of regional hospitals. Acceptance of patients was determined by resource availability (bed and nursing staff) rather than on the basis of perceived ability to wean.
Long term survival after admission to a specialised weaning centre has been reported to be between 15% Neuromuscular/chest wall (n = 47) 19% (n = 9) 66% (n = 31) 15% (n = 7) COPD (n = 41) 56% (n = 23) 20% (n = 8) 24% (n = 10) Surgical (n = 36) 36% (n = 13) 14% (n = 5) 50% (n = 18) Other diagnoses (n = 29) 41% (n = 12) 35% (n = 10) 24% (n = 7)
Percentages are expressed as a proportion of the total number in each diagnostic group.
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3 at 1 year and as good as 54% at 4 years. 1 We found overall survival rates of 58% at 1 year and of 47% at 3 years. To our knowledge, only Schonhofer et al 5 have examined long term survival in separate subpopulations referred to a weaning centre.
Although 76% of our patients with COPD survived to hospital discharge, only 43% of the survivors were alive at 3 years, similar to that reported by Schonhofer et al. 5 COPD has been reported as the cause of ventilator dependence in approximately 25% of all patients who remain ventilator dependent 3 weeks after ICU admission.
14 Specialised weaning centres report rates of liberation from ventilation in COPD of between 22% 7 and 35%. 4 However, in our study, COPD was not associated with a failure to wean-in fact, quite the reverse. Over half of this group (56%) were liberated from ventilation. Admission to ICU in the UK has traditionally been restrictive for patients with COPD. Without measurement of pre-morbid lung function, which was rarely available, it is not possible to determine if the relatively high success of weaning we report was because they were a group who had less severe airflow limitation. Our intensive use of NIV as a bridge to spontaneous breathing may explain the difference. This has proven efficacy in treating acute exacerbations of COPD [15] [16] [17] and in facilitating extubation in the ICU. 18 19 Our data suggest that many patients with COPD who have failed to wean in the ICU can subsequently be liberated from ventilation in centres with appropriate experience and facilities. However, the long term mortality for these patients remains significant.
The patients with neuromuscular/chest wall conditions were a mixed group with both stable (for example, limb girdle myopathy) and progressive diseases (for example, motor neurone disease). Despite a low initial mortality and satisfactory long term survival, a large proportion required persistent ventilatory assistance. This was predominantly nocturnal ventilation (n = 20/31) with independence for much of the day. Smith et al, 3 whose patients had mainly neuromuscular diseases, reported similar findings with a low mortality (10%) and high need for continuing ventilatory support (75%). Schonhofer et al 5 also found better long term survival in patients with neuromuscular conditions than in those with COPD. In our study a high proportion of patients with neuromuscular/chest wall conditions were referred from outside ICUs, which may explain the lower rate of ventilator independence in those referred from external sources. The low mortality in this group suggests that referral to a weaning centre should occur when weaning is delayed, especially as it is likely that there will be a need for continued domiciliary ventilatory support.
Half of the surgical group died before leaving hospital. However, the majority of survivors (69%, 11/16) were still alive at 3 years. Reports that have analysed outcome related to delayed weaning in surgical patients give higher rates of survival 10 and ventilator independence 7 than in medical patients. The older age (71 years (IQR 60-75) v 61 years (IQR 47-68); p = 0.03) in our surgical patients compared with the rest of the group may have been a factor in the higher initial mortality. There was insufficient information to assess fully the effect of coincident medical conditions such as COPD and cardiovascular disease which may have contributed to the high initial mortality observed.
Factors associated with increasing hospital mortality were age, duration of stay in the referring ICU, and APACHE II risk of death. Both Swinburn et al 20 and Cohen et al 21 report poor outcomes in elderly ventilator dependent patients. Despite elderly patients having a higher mortality, age per se did not affect the likelihood of weaning from prolonged mechanical ventilation. The association of ICU length of stay and Costing was originally evaluated in pounds sterling and has been converted to Euros using £1 = J 1.5026.
mortality has been previously reported 22 and is likely to be related to both the underlying diagnosis and complications such as nosocomial infection.
The APACHE II predicted risk of death, which was recorded on admission to the referring ICU, predicted mortality even after admission to the LFU (OR 1.024, p = 0.046). The relationship between severity scoring systems, 23 24 physiological parameters, 4 11 25 and outcome has previously been investigated. There is, however, little published work incorporating both physiological measurements and the underlying diagnosis to help predict outcome. Another factor associated with successful weaning was female sex. Why this should be a factor is unclear, but Scheinhorn et al 23 report similar findings. Studies designed to look specifically at the effect of sex on ICU outcomes have not found any association with mortality or length of stay in the ICU. 26 We know of no published data from the UK to allow comparison of the costs involved in caring for weaning failure patients. Using a similar method of assessment it has been estimated that the cost of stay in an ICU is almost double the cost in a weaning centre. 27 These reduced costs principally arise from the lower staffing ratio. Centres in the USA have shown financial savings compared with ICU care. 28 29 Given the pressure on ICU facilities and the effect on activityespecially in smaller units-through blocking of an ICU bed by long stay patients, there is a strong case for the expansion or creation of regional weaning units such as ours.
Limitations of the study Our study is a retrospective review of all patients referred and transferred to a single unit over a 4 year period. The data collection and analysis were done independently of the clinicians caring for the patients. The number of patients is smaller than from longer established weaning centres in the USA. 1 4-7 10 With the exception of data from Papworth, 3 nothing has previously been published from the UK. 37% of our patients did not meet the generally accepted definition for weaning failure (ventilated >21 days), but all were referred because of anticipated weaning difficulty. Over half the patients were referred from the ICU at St Thomas' Hospital. The reduced length of ICU stay in these patients may have been due either to ease in transferring in-house patients or to a delay in referral of external patients. The statistical analysis shows only the univariate associations. Despite this, the underlying diagnosis remains important and clinically relevant in determining early and late outcomes.
Conclusions
We conclude that many survivors of prolonged mechanical ventilation can be weaned from ventilatory support. Younger patients and those who spent less time in the referring ICU were most likely to survive. Patients with neuromuscular/ chest wall conditions had good long term survival but few were totally liberated from ventilatory support. Long term survival in COPD was poor but, for many, weaning proved possible. Patients with postoperative weaning failure had a high initial mortality but survival after hospital discharge was good. The underlying diagnosis was crucial in determining early and long term survival and the likelihood of weaning from mechanical ventilation. T his study analysed 364 683 patients from an established Dutch primary care database comprising full electronic patient records. Patients were described as exposed (n = 19 459) if they were prescribed acid suppression (proton pump inhibitor (PPI) or H 2 receptor antagonist (H 2 RA)) and were followed until the development of pneumonia or the end of the study period. A total of 977 893 patient-years of data were obtained. The unadjusted relative risk of pneumonia in the exposed group was 4.5 (95% CI 3.8 to 5.1) compared with the non-exposed group. A nested case-control study using 475 patients and 4690 controls was performed to attempt to allow for confounding by indication. Adjusted relative risks for pneumonia in those currently using PPIs or H 2 RAs were 1.89 (95% CI 1.36 to 2.62) and 1.63 (95% CI 1.07 to 2.48), respectively. Interestingly, there appeared to be a dose-response relationship for those taking PPIs and their risk of pneumonia that was not apparent for H 2 RAs. The conclusion is that gastric acid suppression is associated with an increased risk of community acquired pneumonia.
The concept of gastric acid suppression and the development of pneumonia is longstanding and has biological plausibility. Evaluating the link using a randomised controlled trial is unlikely to be feasible. This study has flaws which the authors recognise: its observational nature, the definition of pneumonia, and that confounding variables are possible even with the nested case-control study. This paper will not alter prescribing habits as gastric acid suppression is effective and has an enviable safety record. It should remind us that few treatments are without side effects and that care is needed in high risk patients (elderly, those with pre-existing lung disease, and immunosuppression). 
